NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn's disease patients

作者：Schaeffler Holger; Rohde Maria; Rohde Sarah; Huth Astrid; Gittel Nicole; Hollborn Hannes; Koczan Dirk; Glass Aenne; Lamprecht Georg; Jaster Robert^*

来源：World Journal of Gastroenterology, 2018, 24(11): 1196-1205.

DOI：10.3748/wjg.v24.i11.1196

• Peripheral blood mononuclear cells
• Gene expression
• NOD2
• Lysozyme
• Crohn's disease
• CLEC5A

AIM
To investigate disease-specific gene expression profiles of peripheral blood mononuclear cells (PBMCs) from Crohn's disease (CD) patients in clinical remission.
METHODS
Patients with CD in clinical remission or with very low disease activity according to the Crohn's disease activity index were genotyped regarding nucleotidebinding oligomerization domain 2 (NOD2), and PBMCs from wild-type (WT)-NOD2 patients, patients with homozygous or heterozygous NOD2 mutations and healthy donors were isolated for further analysis. The cells were cultured with vitamin D, peptidoglycan (PGN) and lipopolysaccharide (LPS) for defined periods of time before RNA was isolated and subjected to microarray analysis using Clariom S assays and quantitative realtime PCR. NOD2- and disease-specific gene expression profiles were evaluated with repeated measure ANOVA by a general linear model.
RESULTS
Employing microarray assays, a total of 267 genes were identified that were significantly up- or downregulated in PBMCs of WT-NOD2 patients, compared to healthy donors after challenge with vitamin D and/or a combination of LPS and PGN (P < 0.05; threshold: >= 2-fold change). For further analysis by real-time PCR, genes with known impact on inflammation and immunity were selected that fulfilled predefined expression criteria. In a larger cohort of patients and controls, a disease-associated expression pattern, with higher transcript levels in vitamin D-treated PBMCs from patients, was observed for three of these genes, CLEC5A (P < 0.030), lysozyme (LYZ; P < 0.047) and TREM1 (P < 0.023). Six genes were found to be expressed in a NOD2 -dependent manner (CD101, P < 0.002; CLEC5A, P < 0.020; CXCL5, P < 0.009; IL-24, P < 0.044; ITGB2, P < 0.041; LYZ, P < 0.042). Interestingly, the highest transcript levels were observed in patients with heterozygous NOD2 mutations.
CONCLUSION
Our data identify CLEC5A and LYZ as CD- and NOD2 associated genes of PBMCs and encourage further studies on their pathomechanistic roles.

• 出版日期2018-3-21